Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 106 AL 120

[Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial]

Yu L, Lin SM, Zhou RQ, Tang WJ, Huang PX, Dong Y, Wang J, Yu ZH, Chen JL, Wei L, Xing SL, Cao HJ, Zhao HB.

Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):766-76. doi: 10.3736/jcim20120707.

Disease modifying drugs targeting β-amyloid

Ozudogru SN, Lippa CF.

Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):296-300. doi: 10.1177/1533317512452034.

Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities

Sagare AP, Deane R, Zlokovic BV.

Pharmacol Ther. 2012 Oct;136(1):94-105. doi: 10.1016/j.pharmthera.2012.07.008. Epub 2012 Jul 20.

Hsp90 modulation for the treatment of Alzheimer's disease

Zhao H, Michaelis ML, Blagg BS.

Adv Pharmacol. 2012;64:1-25. doi: 10.1016/B978-0-12-394816-8.00001-5.

Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention

Silva DF, Selfridge JE, Lu J, E L, Cardoso SM, Swerdlow RH.

Adv Pharmacol. 2012;64:83-126. doi: 10.1016/B978-0-12-394816-8.00003-9.

γ-Secretase as a target for Alzheimer's disease

Wolfe MS.

Adv Pharmacol. 2012;64:127-53. doi: 10.1016/B978-0-12-394816-8.00004-0.

Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease

Colca JR, Feinstein DL.

Adv Pharmacol. 2012;64:155-76. doi: 10.1016/B978-0-12-394816-8.00005-2.

scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease

Ma K, Thomason LA, McLaurin J.

Adv Pharmacol. 2012;64:177-212. doi: 10.1016/B978-0-12-394816-8.00006-4.

Beyond amyloid: the future of therapeutics for Alzheimer's disease

Lane RF, Shineman DW, Steele JW, Lee LB, Fillit HM.

Adv Pharmacol. 2012;64:213-71. doi: 10.1016/B978-0-12-394816-8.00007-6.

Tamibarotene: a candidate retinoid drug for Alzheimer's disease

Fukasawa H, Nakagomi M, Yamagata N, Katsuki H, Kawahara K, Kitaoka K, Miki T, Shudo K.

Biol Pharm Bull. 2012;35(8):1206-12. doi: 10.1248/bpb.b12-00314.

Validation of a multiplex assay for simultaneous quantification of amyloid-β peptide species in human plasma with utility for measurements in studies of Alzheimer's disease therapeutics

Lachno DR, Emerson JK, Vanderstichele H, Gonzales C, Martényi F, Konrad RJ, Talbot JA, Lowe SL, Oefinger PE, Dean RA.

J Alzheimers Dis. 2012;32(4):905-18. doi: 10.3233/JAD-2012-121075.

Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?

Teich AF, Arancio O.

Biochem J. 2012 Sep 1;446(2):165-77. doi: 10.1042/BJ20120653.

Immunotherapy for Alzheimer's disease

Wang W, Fan L, Xu D, Wen Z, Yu R, Ma Q.

Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):807-14. doi: 10.1093/abbs/gms065. Epub 2012 Aug 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias